Virtu KCG Holdings’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$419K Sell
43,440
-24,192
-36% -$157K 0.01% 1312
2017
Q1
$402K Buy
+67,632
New +$325K 0.01% 1600
2016
Q4
Sell
-50,554
Closed -$530K 3474
2016
Q3
$530K Buy
+50,554
New +$727K 0.01% 1311
2016
Q1
Sell
-18,709
Closed -$452K 2980
2015
Q4
$452K Buy
18,709
+4,841
+35% +$121K 0.01% 1670
2015
Q3
$340K Buy
13,868
+4,887
+54% +$138K 0.01% 1931
2015
Q2
$210K Buy
+8,981
New +$196K ﹤0.01% 2529
2014
Q4
Sell
-12,016
Closed -$172K 3831
2014
Q3
$172K Sell
12,016
-490
-4% -$7.06K ﹤0.01% 3003
2014
Q2
$199K Buy
12,506
+10,022
+403% +$151K ﹤0.01% 3082
2014
Q1
$45K Buy
+2,484
New +$46.1K ﹤0.01% 3350
2013
Q4
Sell
-1,610
Closed -$19K 3871
2013
Q3
$19K Buy
+1,610
New +$20.3K ﹤0.01% 3620

Other funds holding DVAX

Virtu KCG Holdings's DVAX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Dynavax Technologies (DVAX) stake by 36% in Q2 2017, selling an estimated $157K and leaving 43,440 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #1312.

Virtu KCG Holdings first reported a position in DVAX in Q3 2013 and has held it in 10 quarters since. The position peaked at $530K in Q3 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q2 2017.

  • Virtu KCG Holdings held 43,440 shares of Dynavax Technologies worth $419K as of Q2 2017.
  • Virtu KCG Holdings sold 24,192 Dynavax Technologies shares in Q2 2017, an estimated $157K.
  • Dynavax Technologies made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1312 holding.
  • Virtu KCG Holdings first reported a position in Dynavax Technologies in Q3 2013 and has held it in 10 quarters since.
  • Virtu KCG Holdings's Dynavax Technologies position peaked at $530K in Q3 2016.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.